Chronic Myelogenous Leukemia Overview
32 Questions
2 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which characteristic is specifically associated with Chronic Myelogenous Leukemia (CML)?

  • Hypereosinophilia
  • BCR-abl fusion gene (correct)
  • Loss of hematopoietic stem cells
  • Increased monocytosis
  • What percentage of patients are typically diagnosed in the chronic phase of CML?

  • 85% (correct)
  • 75%
  • 50%
  • 65%
  • What clinical symptom is NOT typically associated with Chronic Myelogenous Leukemia?

  • Epistaxis
  • Menorrhagia
  • Visual disturbances
  • Peripheral neuropathy (correct)
  • Which of the following is a common feature shared by chronic myeloproliferative disorders?

    <p>Splenomegaly</p> Signup and view all the answers

    What is the male-to-female incidence ratio of Chronic Myelogenous Leukemia?

    <p>More common in men</p> Signup and view all the answers

    Which of the following classifications of CML involves the Philadelphia chromosome?

    <p>Classical CML with Philadelphia positive</p> Signup and view all the answers

    How is Chronic Myelogenous Leukemia classified based on cell precursors?

    <p>Classified by the specific cell precursors involved</p> Signup and view all the answers

    What demographic is most commonly affected by Chronic Myelogenous Leukemia?

    <p>Middle-aged and elderly</p> Signup and view all the answers

    What is a characteristic finding in the complete blood count (CBC) of a patient with chronic myeloid leukemia (CML)?

    <p>Normocytic, normochromic anemia</p> Signup and view all the answers

    Which of the following is a phase of Chronic Myelogenous Leukemia?

    <p>Chronic phase</p> Signup and view all the answers

    What would be an expected finding in the bone marrow of a patient with chronic myeloid leukemia?

    <p>Increased myeloid to erythroid (M:E) ratio</p> Signup and view all the answers

    Which environmental factor is linked to an increased risk of developing CML?

    <p>Long-term exposure to benzene</p> Signup and view all the answers

    Which of the following biochemical markers is expected to be increased in a patient with chronic myeloid leukemia?

    <p>Both B and C</p> Signup and view all the answers

    Which immunological marker is positive in chronic myeloid leukemia?

    <p>CD15</p> Signup and view all the answers

    What type of blood cell count pattern is commonly seen in patients with CML?

    <p>Elevated WBC count with moderate thrombocytosis</p> Signup and view all the answers

    What is the significance of the Philadelphia chromosome in chronic myeloid leukemia?

    <p>It is associated with the BCR-ABL fusion gene.</p> Signup and view all the answers

    Which of the following findings would indicate the chronic phase of chronic myeloid leukemia?

    <p>Blasts not more than 10%</p> Signup and view all the answers

    Which hematological exam could show the presence of immature myeloid precursors away from bony trabeculae?

    <p>Bone marrow biopsy</p> Signup and view all the answers

    What is a common peripheral blood film feature in chronic myeloid leukemia?

    <p>Neutrophils with left shift</p> Signup and view all the answers

    In chronic myeloid leukemia, which of the following is a likely cause of increased serum uric acid?

    <p>Increased purine destruction</p> Signup and view all the answers

    What characterizes the accelerated phase of chronic myeloid leukemia (CML)?

    <p>More than 20% basophils in the blood or bone marrow</p> Signup and view all the answers

    Which of the following is associated with the Philadelphia chromosome?

    <p>It produces a specific 210kD tyrosine kinase</p> Signup and view all the answers

    Which laboratory test is NOT typically part of the diagnosis for chronic myeloid leukemia?

    <p>Celiac disease panel</p> Signup and view all the answers

    What is a key effect of the enhanced tyrosine kinase activity seen in CML?

    <p>Promotion of abnormal blood cell production</p> Signup and view all the answers

    What happens to red blood cell and platelet production in chronic myeloid leukemia?

    <p>Production is insufficient due to replacement by blasts</p> Signup and view all the answers

    Which of the following phases is characterized by myeloid blast crises in CML?

    <p>Acute phase with over 1000x blasts</p> Signup and view all the answers

    What is the significance of having a blast count higher than 20% in CML?

    <p>Points towards an accelerated phase</p> Signup and view all the answers

    Which statement accurately describes the symptomatology of chronic myeloid leukemia during its chronic phase?

    <p>Patients can be asymptomatic or have mild symptoms</p> Signup and view all the answers

    How do abnormal myeloid cells affect the body's immune response in CML?

    <p>They cannot function properly, leading to increased infection risk</p> Signup and view all the answers

    What is a likely consequence of excessive proliferation of immature blood cells (blasts) in CML?

    <p>Suppression of normal hematopoiesis</p> Signup and view all the answers

    Signup and view all the answers

    Signup and view all the answers

    Study Notes

    Chronic Myelogenous Leukemia (CML)

    • CML is a clonal myeloproliferative disorder
    • Characterized by a specific genetic abnormality: BCR-abl fusion gene
    • Associated with leukocytosis (increased white blood cells) with a complete left shift
    • Also shows basophilia (increased basophils) and splenomegaly (enlarged spleen) and hepatomegaly (enlarged liver)
    • A myeloproliferative disorder is a group of disorders that are considered clonal malignancies of the hematopoietic stem cells.
    • Other common features of myeloproliferative disorders include splenomegaly, hepatomegaly, increased leukocytosis (increased white blood cells), thrombocytosis (increased platelets), and erythrocytosis (increased red blood cells).
    • Types of myeloproliferative disorders include chronic myelogenous leukemia (CML), myelofibrosis with myeloid metaplasia (MMM), polycythemia vera (PV), and essential thrombocythemia (ET).
    • Synonyms for CML include chronic granulocytic leukemia, chronic myelocytic leukemia

    Classification

    • Based on the presence or absence of Philadelphia chromosome and the cell precursors involved.
    • Includes classical CML with Philadelphia chromosome
    • CML without Philadelphia chromosome
    • CML of neutrophilic cell
    • CML of eosinophilic cell
    • CML of myelomonocyte
    • Juvenile CML

    Epidemiology

    • CML affects all age groups but most common in middle-aged and elderly
    • Incidence is 1-2 per 100,000 people
    • More common in men
    • Represents 15-20% of adult leukemia cases in Western populations
    • Increased cases in populations exposed to atomic bombings (Hiroshima & Nagasaki)
    • Long-term benzene exposure may contribute

    Clinical Features

    • Splenomegaly
    • Gout-like symptoms
    • Anemia
    • Hyperuricemia
    • Bruising
    • Epistaxis
    • Menorrhagia
    • Hemorrhages from other sites
    • Visual disturbance

    Clinical Presentation

    • CML is a malignant blood disorder
    • Involves early hematopoietic cells that become clonally expanded
    • Originates from a single abnormal hematopoietic stem cell which proliferates over time, resulting in blood granulocytosis and marrow granulocytopoiesis
    • Marked by bone marrow hypercellularity

    Phases of CML

    • Chronic phase
    • Accelerated phase
    • Blast crises

    Chronic Phase

    • Approximately 85% of patients are in the chronic phase at diagnosis.
    • Mostly asymptomatic or have mild symptoms.
    • Blast cells are <10%.
    • No splenomegaly
    • No anemia
    • Thrombocytosis
    • Variable duration
    • May progress to accelerated phase

    Accelerated Phase

    • 10-19% blasts in blood or bone marrow
    • 20% basophils in blood or bone marrow

    • Platelet count <100,000 which is unrelated to treatment.
    • Other chromosomal abnormalities may be present
    • Marked splenomegaly and increasing white blood cell count which is unresponsive to therapy

    Blast Crises

    • Final phase of CML evolution
    • Resembles acute leukemia
    • Rapid progression and short survival
    • Diagnosis based on presence of:
      • 20% myeloblasts or lymphoblasts in blood or bone marrow

      • Large clusters of blasts in bone marrow biopsy
      • Development of chloroma (solid focus of leukemia outside bone marrow)

    Pathophysiology

    • Every cell contains 23 pairs of chromosomes
    • The most important cause is the translocation of two chromosomes:
      • Chromosome 9 (ABL gene)
      • Chromosome 22 (BCR gene)
    • This translocation creates the Philadelphia chromosome (BCR-ABL)
    • This new gene produces a specific 210kD tyrosine kinase
    • This tyrosine kinase stimulates uncontrolled production of abnormal blood cells

    General Details of CML

    • Normally, white blood cells grow and divide in a controlled manner
    • In CML, the process gets out of control, causing rapid division without proper maturation.
    • Too many myeloid cells are produced, releasing into the bloodstream.
    • Immature myeloid cells are called blasts and cannot function properly.
    • Blast cells fill bone marrow and block normal blood cell production.
    • This impairment leads to an increased risk of infection.

    Lab Diagnosis

    • Biochemical tests
    • Bone marrow examination
    • Immunological markers
    • Cytogenetics
    • Molecular assays

    Lab Investigation of CML

    • Complete blood count (CBC): Increased white blood cell count, and platelet count
    • Blood cell count- WBC range from 50-500 x109/L
    • Peripheral blood film examination:
      • Normocytic, normochromic anaemia
      • Neutrophils showing a left shift
      • Eosinophils normal or sometime increased
      • NRBCs are seen
    • Absolute Basophilia
    • Moderate thrombocytosis
    • Macrocytosis
    • Hypogranulated myeloid cells

    Biochemical Findings

    • Increased serum uric acid (due to increased purine destruction)
    • Increased serum iron
    • Increased serum B12 and B12 binding capacity
    • Decreased NAP score
    • Elevated serum LDH
    • Elevated Ca++

    Immunological Markers

    • CD13 +
    • CD14 +
    • CD15 +
    • CD33 +

    Specialized Techniques

    • Chromosome analysis: identifying Philadelphia chromosome (Ph+) and BCR-ABL positivity.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz provides an overview of Chronic Myelogenous Leukemia (CML), a clonal myeloproliferative disorder characterized by the BCR-abl fusion gene. Explore its symptoms, including leukocytosis, basophilia, and splenomegaly, as well as other related myeloproliferative disorders. Test your knowledge on this vital hematological condition.

    More Like This

    Chronic Myelogenous Leukemia (CML)
    10 questions
    Chronic Myelogenous Leukemia Overview
    20 questions
    Drug Discovery Process for CML
    28 questions

    Drug Discovery Process for CML

    MiraculousBildungsroman4805 avatar
    MiraculousBildungsroman4805
    Use Quizgecko on...
    Browser
    Browser